Sana Biotechnology SANA
NASDAQ SANA
$2.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Sana Biotechnology (SANA) reported Return on Capital Employed [ROCE] of -78.46% for Q2 2026, down 8.69 percentage points from -69.77% a year earlier but up 1.90 percentage points from the prior quarter.

Analysis

Sana Biotechnology (SANA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Sana Biotechnology posted Return on Capital Employed [ROCE] of -65.83%, down 9.92 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for three consecutive years, with a four-year change of -22.86 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -55.92% in FY2024 (-9.35 pp), -46.57% in FY2023 (-15.04 pp), -31.53% in FY2022 (+11.44 pp) and -42.97% in FY2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -80.36% in Q1 2026 and a high of -20.89% in Q1 2022.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of -12.08 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2022 (a gain of 23.26 percentage points); the low point was Q1 2026 (a drop of 32.05 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -80.36% (Q1 2026), -72.05% (Q4 2025) and -66.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Sana Biotechnology 864.99 Mn 864.99 Mn - -78.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -78.46%
Mar 31, 2026 -80.36%
Dec 31, 2025 -72.05%
Sep 30, 2025 -66.11%
Jun 30, 2025 -69.77%
Mar 31, 2025 -48.31%
Dec 31, 2024 -56.26%
Sep 30, 2024 -57.65%
Jun 30, 2024 -42.20%
Mar 31, 2024 -56.06%
Dec 31, 2023 -54.91%
Sep 30, 2023 -47.18%
Jun 30, 2023 -59.90%
Mar 31, 2023 -47.64%
Dec 31, 2022 -36.39%
Sep 30, 2022 -36.85%
Jun 30, 2022 -32.81%
Mar 31, 2022 -20.89%
Dec 31, 2021 -32.99%
Sep 30, 2021 -31.10%
API Access

Sana Biotechnology Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SANA&period=max&api_key=YOUR_API_KEY